183 related articles for article (PubMed ID: 6270556)
1. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis.
Tosato G; Steinberg AD; Blaese RM
N Engl J Med; 1981 Nov; 305(21):1238-43. PubMed ID: 6270556
[TBL] [Abstract][Full Text] [Related]
2. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
5. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.
Depper JM; Bluestein HG; Zvaifler NJ
J Immunol; 1981 Nov; 127(5):1899-902. PubMed ID: 6271870
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
[TBL] [Abstract][Full Text] [Related]
7. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
Tosato G; Straus S; Henle W; Pike SE; Blaese RM
J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
[TBL] [Abstract][Full Text] [Related]
8. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.
Tosato G; Magrath IT; Koski IR; Dooley NJ; Blaese RM
J Clin Invest; 1980 Aug; 66(2):383-8. PubMed ID: 6249850
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and rheumatoid arthritis.
Balandraud N; Roudier J; Roudier C
Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
[TBL] [Abstract][Full Text] [Related]
10. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.
Tosato G; Steinberg AD; Yarchoan R; Heilman CA; Pike SE; De Seau V; Blaese RM
J Clin Invest; 1984 Jun; 73(6):1789-95. PubMed ID: 6327772
[TBL] [Abstract][Full Text] [Related]
11. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
12. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
Birx DL; Redfield RR; Tosato G
N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Epstein-Barr virus receptor on lymphoblastoid cell lines from subsets of patients with rheumatoid arthritis.
Kahan A; Charriaut-Marlangue C; Kahan A; Barel M; Menkes CJ; Amor B; Frade R
J Rheumatol; 1986 Dec; 13(6):1024-7. PubMed ID: 3494120
[TBL] [Abstract][Full Text] [Related]
16. Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells.
McCaughan GW; Brown MH; Callard RE
Immunology; 1986 Aug; 58(4):597-602. PubMed ID: 3015782
[TBL] [Abstract][Full Text] [Related]
17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
19. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
20. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
